Bridget Chappell
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
-
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Radiopharmaceutical Chemistry and Applications 3
- Monoclonal and Polyclonal Antibodies Research 1
-
- Lung Cancer Treatments and Mutations 2
- Prostate Cancer Treatment and Research 1
- Renal cell carcinoma treatment 1
- Co-authors
- Andrew M. Scott (8 shared papers)Timothy Saunder (7 shared papers)Wendie Hopkins (5 shared papers)Niall C. Tebbutt (4 shared papers)Fook-Thean Lee (3 shared papers)Fiona E. Smyth (3 shared papers)Carmel Murone (3 shared papers)Aurora Poon (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Clinical Cancer Research (2 papers)Journal of Nuclear Medicine (1 paper)PubMed (1 paper)World Journal of Nuclear Medicine (1 paper)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Bridget Chappell
7 papers receiving 167 citations
Peers
Comparison fields: 5 of 37
- Radiology, Nuclear Medicine and Imaging 103
- Oncology 77
- Immunology 37
- Molecular Biology 73
- Genetics 6
Countries citing papers authored by Bridget Chappell
This map shows the geographic impact of Bridget Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bridget Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bridget Chappell more than expected).
Fields of papers citing papers by Bridget Chappell
This network shows the impact of papers produced by Bridget Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bridget Chappell. The network helps show where Bridget Chappell may publish in the future.
Co-authors
The 25 scholars most cited alongside Bridget Chappell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 64 | |
| 2 | 2009 | 60 | |
| 3 | 2014 | 27 | |
| 4 | A pilot study of monoclonal antibody cG250 and low dose subcutaneous IL-2 in patients with advanced renal cell carcinoma. | 2007 | 24 |
| 5 | 2007 | 1 | |
| 6 | 2006 | 1 | |
| 7 | 2008 | 1 | |
| 8 | 2025 | 0 |
About Bridget Chappell
Bridget Chappell is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Molecular Biology, Oncology and Genetics, having authored 8 papers that have together received 178 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (3 papers), Lung Cancer Treatments and Mutations (2 papers), Prostate Cancer Treatment and Research (1 paper), Renal cell carcinoma treatment (1 paper), Cancer Genomics and Diagnostics (1 paper), Monoclonal and Polyclonal Antibodies Research (1 paper), Glycosylation and Glycoproteins Research (1 paper) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (103 citations), Oncology (77 citations), Immunology (37 citations), Molecular Biology (73 citations) and Genetics (6 citations). Bridget Chappell has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Andrew M. Scott, Timothy Saunder, Wendie Hopkins, Niall C. Tebbutt, Fook-Thean Lee, Fiona E. Smyth, Carmel Murone, Aurora Poon, Martin W. Brechbiel and Rebecca Herbertson. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Nuclear Medicine, PubMed and World Journal of Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.